Cargando…

87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up

BACKGROUND: The DONATE HCV Trial demonstrated that hearts and lungs can be safely transplanted from HCV-infected donors using a shortened, 4-week, pre-emptive course of direct-acting antivirals (DAA). The 6-month results from that study of 35 patients are encouraging, but longer-term data from a lar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolley, Ann E, Goldberg, Hilary J, Singh, Steve K, Mehra, Mandeep R, Givertz, Michael M, Coppolino, Antonio, Cheng, Vivien, Fanikos, John, Harrington, David P, Mallidi, Hari R, Baden, Lindsey R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810410/ http://dx.doi.org/10.1093/ofid/ofz359.011

Ejemplares similares

The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
por: Woolley, Ann E., et al.
Publicado: (2022)

94. Infectious Complications of Left Ventricular Assist Devices
por: Harris, Courtney, et al.
Publicado: (2021)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
por: Axelrod, David A., et al.
Publicado: (2020)

Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation
por: Sise, Meghan E., et al.
Publicado: (2020)

Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors
por: Wiesmann, F., et al.
Publicado: (2014)

Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
por: Czarnecka, Paulina, et al.
Publicado: (2022)

Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support
por: Levesque, Amy A., et al.
Publicado: (2019)

2123. The Impact of Staphylococcus aureus Peri-transplant Cultures on Six-Month Outcomes in Lung Transplantation
por: Harris, Courtney E, et al.
Publicado: (2022)

Antibody Responses to COVID-19 Vaccination in Left Ventricular Assist Devices
por: Jering, K., et al.
Publicado: (2022)

1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease
por: Trindade, Anil J., et al.
Publicado: (2021)

Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
por: Eckman, Mark H., et al.
Publicado: (2021)

Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China
por: Zhang, Hedong, et al.
Publicado: (2022)

2714. Invasive Fungal Disease in Lung Transplant Recipients: Incidence, Risk Factors, and Outcomes
por: Kovac, Victor, et al.
Publicado: (2023)

Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis
por: Feng, Zepei, et al.
Publicado: (2022)

Dilemma of organ donation in transplantation and the COVID-19 pandemic
por: Woolley, Ann E., et al.
Publicado: (2020)

Outcome of Kidney Transplants from Viremic and Non-Viremic Hepatitis C Virus Positive Donors into Negative Recipients: Results of the Spanish Registry
por: Franco, Antonio, et al.
Publicado: (2023)

Elite and viremic HIV-1 controllers in West Africa
por: N’takpé, Jean Baptiste, et al.
Publicado: (2022)

Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study
por: Fouquet, Baptiste, et al.
Publicado: (2015)

ZIKV Demonstrates Minimal Pathologic Effects and Mosquito Infectivity in Viremic Cynomolgus Macaques
por: Azar, Sasha R., et al.
Publicado: (2018)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Dengue transmission model by means of viremic adult immuno-competent mouse
por: Runtuwene, Lucky Ronald, et al.
Publicado: (2014)

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers
por: Gonzalo-Gil, Elena, et al.
Publicado: (2017)

Low Aedes aegypti Vector Competence for Zika Virus from Viremic Rhesus Macaques
por: Fernandes, Rosilainy Surubi, et al.
Publicado: (2020)

A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection
por: Knapp, Susanne, et al.
Publicado: (2011)

HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California
por: Page, Kimberly, et al.
Publicado: (2017)

Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring
por: Almufleh, Aws, et al.
Publicado: (2020)

Tonsil histopathology in HIV-infected versus HIV-uninfected adults
por: Essa, Ridwaan, et al.
Publicado: (2019)

Sustained Viremic Control in HIV-Infected Patient: Case Report from Nepal
por: Khadka, Sundar, et al.
Publicado: (2018)

Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
por: Sayad, Babak, et al.
Publicado: (2018)

Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
por: Zhu, Yuanjia, et al.
Publicado: (2020)

Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice
por: Barthold, S. W., et al.
Publicado: (1992)

EXM-87-09: 03/09/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-17: 19/11/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-20: 17/12/87
por: Martucci, P, et al.
Publicado: (1988)

EXM-87-14: 22/10/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-18: 26/11/87
por: Martucci, P
Publicado: (1987)

Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial
por: Cunningham, Jonathan W., et al.
Publicado: (2019)

Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes
por: Weber, Brittany, et al.
Publicado: (2021)

RELATIONSHIPS BETWEEN MYOCARDIAL INJURY, INDEX HOSPITALIZATION CHARACTERISTICS, AND LONGER-TERM OUTCOMES IN SARS-COV-2 INFECTION
por: Weber, Brittany, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ptimd657hjdsajudl8g7sjl0p2